The ongoing appraisal for adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, abatacept and tocilizumab for the treatment of rheumatoid arthritis (review of TA guidance 130, 186, 224, 234 and part review of TA guidance 225 and 247) seems to have encountered a problem. From the NICE website:“The current scheduled second Committee meeting on 7 January 2014 for this appraisal topic has been cancelled. This is to allow NICE to work towards releasing an executable model for consultee and commentator comment and an external review of the evidence for disease progression in rheumatoid
Sheffield TelegraphNew Scheme Offers Street Vouchers to Mothers to Boost BreastfeedingTopNews New ZealandDr. Clare Relton from the University of Sheffield's School of Health and Related Research is a principal investigator. He said, "Babies who are breastfed have fewer health problems such as upset tummies and chest infections, and are less likely to ...Sheffield mums in breastfeeding research study'Vouchers will penalise bottle-feeding mothers'
The GuardianThe worst breastfeeding initiative I've ever come acrossThe GuardianResearchers at Sheffield University's School of Health and Related Research, funded in part by the government's National Prevention Research Initiative, have decided to bribe women into doing something that "they" have decided is best. But no woman in ...The nanny state? Mothers could be given shopping vouche
Principal investigator Dr Clare Relton, from the University of Sheffield's School of Health and Related Research, said: “Babies who are breastfed have fewer health problems such as upset tummies and chest infections, and ...
Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 25 papers were listed this time. Here's a few in our areas of research interest:Eggington S, Valldeoriola F, Chaudhuri KR, et al. The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease. J